发明名称 Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
摘要 Nucleic acid molecules and compositions comprising: a nucleic acid sequence that encodes IL-12 p35 subunit or a functional fragment thereof and/or a nucleic acid sequence that encodes IL-12 p40 subunit or a functional fragment thereof, are disclosed. The nucleic acid molecules and compositions further comprising a nucleic acid sequence that encodes an immunogen are also disclosed. Method of modulating immune response and methods of inducing an immune response against an immunogen are disclosed. Therapeutic and prophylactic vaccination methods are also disclosed.
申请公布号 US9272024(B2) 申请公布日期 2016.03.01
申请号 US201214365086 申请日期 2012.12.11
申请人 The Trustees of the University of Pennsylvania 发明人 Weiner David B.;Morrow Matthew P.;Yan Jian
分类号 C12N5/10;C07K14/54;A61K38/20;A61K39/245;A61K39/00;C12N7/00;C12N7/02;C12N15/63;C12P21/02 主分类号 C12N5/10
代理机构 Riverside Law LLP 代理人 Riverside Law LLP
主权项 1. A composition that comprises a) a nucleic acid sequence that encodes IL-12 p35 subunit and b) a nucleic acid sequence that encodes IL-12 p40 subunit, wherein the nucleic acid sequence that encodes IL-12 p35 subunit is at least 98% homologous to SEQ ID NO:1 and encodes a protein at least 98% homologous to SEQ ID NO:2, and the nucleic acid sequence that encodes IL-12 p40 subunit is at least 98% homologous to SEQ ID NO:3 and encodes a protein at least 98% homologous to SEQ ID NO:4.
地址 Philadelphia PA US